Executive Team
NeurExpand’s executive team has a history of success growing startups and building companies into world class global brands.
David Abramson
Executive Chairman
Mr. Abramson is executive chairman and principal of NeurExpand. In this capacity, he provides day-to-day senior leadership and guidance in the development of corporate strategy. From 2006-2011, Mr. Abramson served as President of Martek Biosciences Corporation, playing a key role in transitioning the biotechnology company from a R&D operation to a profitable commercial organization with over $470 million in annual sales. During his tenure, Martek’s flagship brand, life’sDHA™ grew to 99.5% market penetration in the U.S. infant formula market, and became an essential ingredient in consumer product goods, dietary supplements and animal feeds worldwide. In 2011, Mr. Abramson and his executive team facilitated the sale of Martek to Royal DSM N.V. for close to $1.1 billion. Prior to joining Martek, Mr. Abramson was the executive vice president and general counsel for U.S. Foodservice and executive vice president for Legal Affairs at Ahold, U.S.A. Between 1994-2003, he directed acquisitions which increased the company’s business more than 500%. He also played a leadership role in the ultimate sale of U.S. Foodservice to Royal Ahold, N.V. for a price in excess of $4.0 billion. Mr. Abramson has served on the boards of multiple healthcare and community organizations. Currently, he is a board member of the Wellness Institute of the Cleveland Clinic, Cleveland, Ohio, and Smart Tots, a non-profit organization funding research for pediatric anesthesia safety.
Steve Dubin
Vice-Chairman
Mr. Dubin is vice-chairman and principal of NeurExpand. He serves as a senior advisor in the development of corporate strategy and performance. From 2006-2011, Mr. Dubin served as CEO of the Martek Biosciences Corporation, overseeing its transformation from a biotechnology R&D company to a profitable commercial organization with over $470 million in annual sales. During his tenure, Martek’s flagship brand, life’sDHA™ grew to 99.5% market penetration in the U.S. infant formula market, and became an essential ingredient in consumer product goods, dietary supplements and animal feeds worldwide. In 2011, Mr. Dubin and his executive team facilitated the sale of Martek to Royal DSM N.V. for close to $1.1 billion. Prior to joining Martek, Mr. Dubin spent 12 years in executive banking roles. His experience also includes work with and financing for a variety of early-stage technology companies. Mr. Dubin chairs the Maryland Economic Development Commission and serves on the boards of two large universities.
Dr. Majid Fotuhi, M.D., Ph.D.
Founder and Chief Medical Officer
Majid Fotuhi is Chief Medical Officer and principal of NeurExpand, the successor to the Neurology Institute for Brain Health and Fitness, which he founded in 2010. Regarded as one of the nation’s foremost authorities on memory loss and dementia, Dr. Fotuhi received his medical degree (cum laude) from Harvard Medical School in Boston and his Ph.D. in neuroscience from Johns Hopkins University in Baltimore. He completed his neurology residency and fellowship training at Johns Hopkins Hospital. Dr. Fotuhi has devoted his career to finding the most effective ways to treat dementia. He has harnessed his knowledge of neuroscience and clinical medicine to develop the nation’s first multidisciplinary treatment protocol, which now helps patients of all ages to enhance their brain performance.
Jeff Hamet
President
Mr. Hamet is president of NeurExpand. In this capacity, he is responsible for overseeing all aspects of the company’s growth, operations, and financial management. He brings a successful record of building and managing fast-growing organizations in complex, evolving markets. From 2004-2012, Mr. Hamet served as Vice President and Corporate Controller of Martek Biosciences Corporation during a period of enormous growth for the biotech company. During his tenure, revenues increased from approximately $100 million to over $470 million, with a dramatic increase in the number of employees, physical locations and revenue streams. He oversaw the implementation of systems, initiatives, and controls necessary to effectively manage this growth, with such growth leading to the company’s 2011 sale to Royal DSM, N.V., for nearly $1.1 billion. Prior to joining Martek, Mr. Hamet served as a senior financial executive at various public and privately held companies, spanning multiple industries, and ranging in size from startup to mature enterprises.
Chris Lindsay
COO & Chief Commercial Officer
Mr. Lindsay serves as Chief Operating Officer and Chief Commercial Officer at NeurExpand. In this capacity, he directs company operations and leads strategic market planning and development. Prior to joining NeurExpand, Mr. Lindsay played a key role in the growth of Martek Biosciences Corporation. As vice president of the company’s dietary supplements and pharmaceutical business, Mr. Lindsay worked with customers to include Martek’s branded ingredients in more than 300 consumer packaged good products, growing his division’s revenue by more than ten-fold. During his 20-year career at Martek, he held key management roles in R&D, Operations, Sales and Marketing, and played an integral role in the discovery, development and commercialization of technologies that helped the transition from a start-up biotech company to a highly profitable commercial organization.
Steven S. Cohen, F.A.C.H.E.
Senior Advisor
Mr. Cohen brings more than 30 years of leadership experience and expertise as a hospital and health system executive. Previously, he served as senior vice president, Integrated Operations at MedStar Health, a regional healthcare system with a network of 10 hospitals and 20 other health-related businesses across Maryland and Washington, DC. His responsibilities included comprehensive home care, physician practices, pharmacy services, laboratories, imaging and facilities management. Cohen was also responsible for the system-wide redesign and integration process that made MedStar the area’s largest healthcare system.